Updated: February 13, 2026
How to Help Your Patients Save Money on Theo-24 XR: A Provider's Guide to Savings Programs
Author
Peter Daggett

Summarize with AI
- Current Pricing Landscape for Generic Theophylline ER
- No Manufacturer Savings Card — But Many Alternatives Exist
- Patient Assistance Programs for Uninsured or Underinsured Patients
- Insurance Considerations and Prior Authorization
- Mail-Order Pharmacy for Long-Term Patients
- Practical Cost Conversation Script
- Helping Patients Use medfinder
A provider's guide to helping patients save money on Theo-24 XR (theophylline ER) in 2026 — discount programs, patient assistance, insurance strategies, and cost conversations.
Theophylline extended release (Theo-24 XR) is one of the most affordable respiratory medications available — generic formulations typically cost $10–$40 per month. But for patients with no insurance, high deductibles, or fixed incomes, even modest medication costs can be a barrier to adherence. Separately, the ongoing supply shortage can push patients to pay premium prices at specialty pharmacies or online sources when their usual pharmacy is out of stock.
This guide equips providers with the information needed to address cost barriers during clinical encounters.
Current Pricing Landscape for Generic Theophylline ER
Prices vary significantly between pharmacies and by strength. Providers should be aware of these benchmarks when counseling patients:
Retail cash price (30-day supply, no insurance): $10–$40 depending on strength and pharmacy.
With GoodRx or SingleCare discount card: As low as $4–$15 per month for most strengths. Price varies by pharmacy — encourage patients to compare across locations.
Walmart $4/$10 generic program: Theophylline is included at many Walmart pharmacy locations — $4 for 30-day supply, $10 for 90-day supply. This is often the lowest cash price available.
With insurance (most plans): Typically $0–$15 copay as a Tier 1 preferred generic on most commercial plans and Medicare Part D.
300 mg tablets (Drugs.com pricing): From approximately $79 for 90 tablets at retail; significantly lower with coupons.
No Manufacturer Savings Card — But Many Alternatives Exist
Because Theo-24 XR is now available only as a generic (the original brand has been discontinued), there are no manufacturer copay assistance programs. Inform patients of this upfront so they don't waste time searching. Instead, redirect them to:
Free discount card programs: GoodRx, SingleCare, RxSaver, Optum Perks. These are free and can be used regardless of insurance status. GoodRx can be printed, displayed on a smartphone, or sent directly to the pharmacy in some cases.
Retail $4 generic programs: Walmart and some regional pharmacy chains include theophylline on their $4 generic drug lists.
Patient Assistance Programs for Uninsured or Underinsured Patients
For patients with no insurance or who have exhausted other savings options:
PAN Foundation: Provides financial assistance for patients with chronic lung conditions. Eligibility is income-based. Providers can refer patients to panfoundation.org.
NeedyMeds.org: Comprehensive database of patient assistance programs, free clinics, and drug discount programs. Patients or staff can search by drug name.
RxAssist.org: Similar resource with a focus on helping both patients and providers navigate manufacturer and non-profit assistance programs.
State Pharmaceutical Assistance Programs (SPAPs): Many states offer additional prescription assistance for elderly and low-income residents. Eligibility varies by state.
Insurance Considerations and Prior Authorization
Generic theophylline ER is classified as a Tier 1 preferred generic on most commercial insurance plans and Medicare Part D formularies. This typically means:
No prior authorization required for standard doses.
Copay of $0–$15 per month for most plans.
Covered under Medicare Part D as a standard Tier 1 generic with low or no copay.
When patients are switching from theophylline to an alternative due to the shortage, prior authorization may be required for inhaled alternatives (e.g., tiotropium, ICS/LABA combinations). In these cases, document the shortage as the clinical rationale and provide a brief letter of medical necessity.
Mail-Order Pharmacy for Long-Term Patients
For stable patients on long-term theophylline therapy, prescribing a 90-day supply through a mail-order pharmacy (typically available through their insurance plan) offers two advantages: lower per-unit cost compared to monthly fills, and access to different supply chains that may have better stock consistency during the shortage. Consider writing 90-day supply prescriptions for appropriate patients.
Practical Cost Conversation Script
During patient visits, a brief cost conversation can uncover barriers before they lead to non-adherence:
"Are you having any trouble finding or affording your theophylline prescription?" This single question can surface both supply and cost barriers. If patients say yes, immediately point them to GoodRx and medfinder, and document the referral.
Helping Patients Use medfinder
When patients are struggling with both availability and cost, medfinder for Providers allows you to check pharmacy availability near the patient's location. By confirming which pharmacies have stock, you can direct patients to specific locations — including those where their discount card offers the lowest price. This combination of stock confirmation and cost optimization addresses both barriers simultaneously.
See also our provider's guide to helping patients find Theo-24 XR in stock for additional strategies.
Frequently Asked Questions
Generally no. Generic theophylline extended-release is classified as a Tier 1 preferred generic on most commercial insurance plans and Medicare Part D formularies. Standard doses typically do not require prior authorization. However, if your patient is switching to an inhaled alternative due to the shortage, prior authorization may be required for the new medication.
Document: (1) the patient-reported access issue (shortage, cost), (2) resources provided (GoodRx, medfinder, patient assistance referral), (3) any prescribing changes made in response (strength substitution, 90-day supply, alternative medication), and (4) the plan for follow-up serum monitoring if any dose or manufacturer changes were made.
Yes. A letter documenting that the theophylline shortage (active as of 2026, per ASHP) necessitated the switch to an inhaled alternative is appropriate. Include the patient's diagnosis, current treatment history, the specific supply challenge, and the clinical decision to transition. This supports prior authorization requests for LAMAs, ICS/LABAs, or other inhaled maintenance therapies.
Prices vary by pharmacy location and fluctuate over time. GoodRx and SingleCare are typically the most competitive, with prices starting at around $4–$29 per 30-day supply depending on strength. Encourage patients to compare prices at 2–3 pharmacies using multiple discount cards, as the same medication can vary by $10–$20 between stores.
During the Medicare Part D coverage gap (donut hole), patients pay reduced prices for generic drugs — typically 25% of the drug cost. For a low-cost generic like theophylline, this is usually still very affordable. Additionally, patients can use GoodRx at the pharmacy even if they have Medicare — the discount often beats the coverage gap price. Note that using GoodRx for a Medicare patient means the purchase won't count toward their out-of-pocket maximum.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Theo-24 XR also looked for:
More about Theo-24 XR
34,034 have already found their meds with Medfinder.
Start your search today.





